Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum levels of osteoprotegerin and osteoprotegerin polymorphisms in Gaucher disease.

British journal of haematology - 1 Apr 2006

Magal Itai, Lebel Ehud, Altarescu Gheona, Itzchaki Menachem, Rudensky Bernard, Foldes A Joseph, Zimran Ari, Elstein Deborah

Abstract excerpt

Bone involvement in Gaucher disease causes disability and reduced quality of life; loss of function and pain are important indications for enzyme replacement therapy. The purpose of this study was to ascertain whether osteoprotegerin (OPG), which decreases osteoclast activity, is indicative of incipient bone involvement by comparing OPG serum levels to Gaucher disease severity (SSI) and bone mineral density...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Bone Density

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gaucher Disease

Share to Glycoproteins

Share to Osteoprotegerin

Share to Receptors, Cytoplasmic and Nuclear

Share to Receptors, Tumor Necrosis Factor

Source

Identifiers

PMID: 16512834
DOI: 10.1111/j.1365-2141.2006.05978.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum levels of osteoprotegerin and osteoprotegerin polymorphisms in Gaucher disease.PMID 16512834Read ↗

Skeletal involvement in Gaucher disease: An observational multicenter study of prognostic factors in the Argentine Gaucher disease patients.Semantic proximity Read ↗

The interleukin-6 promoter polymorphism in Gaucher disease: a new modifier gene?Semantic proximity Read ↗

Effect of vitamin D receptor (VDR) genotypes on the risk for osteoporosis in type 1 Gaucher disease.Semantic proximity Read ↗

Bone density in Type 1 Gaucher disease.Semantic proximity Read ↗

Biochemical markers of bone turnover as tools in the evaluation of skeletal involvement in patients with type 1 Gaucher disease.Semantic proximity Read ↗

Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: a study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry.Semantic proximity Read ↗

The influence of genetic variability and proinflammatory status on the development of bone disease in patients with Gaucher disease.Semantic proximity Read ↗

Molecular aspects of osteopathy in type 1 Gaucher disease: correlation between genetics and bone density.Semantic proximity Read ↗

Enzyme replacement therapy and bony changes in Egyptian paediatric Gaucher disease patients.Semantic proximity Read ↗

Generation of osteoclasts from type 1 Gaucher patients and correlation with clinical and genetic features of disease.Semantic proximity Read ↗

Phenotype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications.Semantic proximity Read ↗

Histologic findings of femoral heads from patients with Gaucher disease treated with enzyme replacement.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.